Available Projects

Company 1

Company 1 is on the brink of a commercial breakthrough with its innovative medical technology device. It has already achieved FDA and CE approvals and a proven 100% success rate in over 1,600 trials.

With its final round of funding, Company 1 is poised to rapidly scale production and expand into new markets, setting the stage for a projected exit within 12-24 months post-funding.

This growth phase offers investors a unique opportunity to gain early entry into a high-demand medical device company before its expected surge in value.


LOCATION:

USA

INDUSTRY:

Medical Technology

PRODUCT:

Company Shares

INVESTMENT TYPE:

Capital Growth

FUNDING REQUIRED:

$USD 15,000,000

MIN. INVESTMENT:

$USD 20,000

MIN. TERM:

12 - 24 Months

Company 2

Company 2 is strategically positioned to capitalise on the booming medical cannabis market in Europe, with proprietary telemedicine solutions and exclusive high-quality cannabis products.

As Company 2 completes its final funding round, the company is focused on expanding its footprint in the Swiss and German markets, aiming to secure a substantial share of this fast-growing sector.

Investors can benefit from Company 2's next stages, where market expansion and a planned trade sale are expected to drive significant increases in share

value.


LOCATION:

Switzerland & Germany

INDUSTRY:

Medical Cannabis

PRODUCT:

Company Shares

INVESTMENT TYPE:

Capital Growth

FUNDING REQUIRED:

CHF 24,700,000

MIN. INVESTMENT:

CHF 24,000

MIN. TERM:

18 - 24 Months

Company 3

Company 3's Rainforest CO2 Reduction Project combines financial growth with high-impact ESG value. By acquiring and preserving large tracts of rainforest in Paraguay, Company 3 offers investors fixed returns backed by government payments and comprehensive insurance.

As the project expands, its value is expected to increase in alignment with global ESG demand, making this a timely investment with attractive annual returns and a secure exit strategy.

Investors can benefit from bi-annual return payments, as well as an attractive 'kicker payment' at the end of the term.


LOCATION:

Switzerland & Paraguay

INDUSTRY:

Rainforest Preservation

PRODUCT:

Bond

INVESTMENT TYPE:

Mixed (Income & CG)

FUNDING REQUIRED:

CHF 63,750,000

MIN. INVESTMENT:

CHF 10,000

MIN. TERM:

5 Years

Company 4

Company 4 is launching a unique seed-stage digital token offering backed by gold and built on Bitcoin Layer 2 infrastructure. The platform combines blockchain security with real-world utility, aiming to reshape digital finance with speed, transparency, and global reach.

Using a proprietary smart contract framework, the project enables seamless development of decentralized apps and payment solutions. Early adopters benefit from access to an ecosystem designed for both institutional and retail growth.

This exclusive opportunity offers limited access at a fixed early-stage rate, with tokens set to list later in 2025.


LOCATION:
Luxembourg

INDUSTRY:

Crypto

PRODUCT:

Utility Token

INVESTMENT TYPE:

Mixed (Income & CG)

FUNDING REQUIRED:

$1,500,000 (Seed Round)

MIN. INVESTMENT:

-

MIN. TERM:

12 Months

Get In Touch